Citigroup Maintains Neutral on QuidelOrtho, Lowers Price Target to $13
Quidel Corporation
Quidel Corporation QDEL | 0.00 |
Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:
QDEL) with a Neutral and lowers the price target from $30 to $13.
